Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Bunzl Share Price
  4. Bunzl Share Regulatory News
  5. Director Declaration

Pin to quick picksBunzl Regulatory News (BNZL)

Bunzl Information

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,430.00    40.00 (1.67%)
Bid:
2,428.00
Ask:
2,432.00
Spread: 4.00 (0.165%)
Market Cap: £7.80b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Director Declaration

31 Mar 2016 12:05

RNS Number : 7001T
Bunzl PLC
31 March 2016
 

In accordance with paragraph 9.6.14 of the Listing Rules, Bunzl plc confirms that Michael Roney, who as previously announced will be retiring from the Board of Bunzl plc on 20 April 2016, has been appointed as Non-Executive Director, Deputy Chairman and Chairman Designate of Grafton Group plc with effect from 1 May 2016 and will assume the role of Chairman on 1 January 2017.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNEANDFDDPKEEF
12345678910
Date   Source Headline
21st Nov 20247:00 amRNSTransaction in Own Shares
20th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSPublication of Admission Particulars
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 202412:21 pmRNSHolding(s) in Company
6th Nov 202410:18 amRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 202411:22 amRNSHolding(s) in Company
5th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20242:29 pmRNSBlock listing Interim Review
1st Nov 20241:42 pmRNSTotal Voting Rights
1st Nov 20247:00 amRNSTransaction in Own Shares
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 20244:20 pmRNSDirector/PDMR Shareholding
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTrading Statement
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20249:15 amRNSIssue of Debt
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20245:10 pmRNSDirector/PDMR Shareholding
2nd Oct 20245:02 pmRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20242:38 pmRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
LVCG
Live Company
LSE
0.00%
CHRT
Cohort
LSE
-1.91%
JZCP
Jz Capital
LSE
0.00%
AAS
Aberdeen Asia
LSE
-0.23%
VRP
VRP.L
LSE
0.00%
Trending
MAC
Marechale Cap.
LSE
42.47%
HE1
Helium One
LSE
6.28%
ALRT
Defence Holdings
LSE
0.00%
NEO
Neo Energy Metals
LSE
-7.30%
IMM
Immupharma
LSE
-5.87%